TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharma Systems AB
Closing information (x1000 EUR)
| Closing information | 2025/06 (consolidated) | 2024/06 (consolidated) | 2023/06 (consolidated) |
| Turnover |
2,225
|
1,872
|
3,082 |
| Financial expenses |
16
|
22
|
18 |
| Earnings before taxes |
-163
|
-294
|
29 |
| EBITDA |
-84
|
-200
|
200 |
| Total assets |
1,889
|
2,055
|
1,937 |
| Current assets |
1,359
|
1,476
|
1,278 |
| Current liabilities |
485
|
525
|
328 |
| Equity capital |
1,280
|
1,256
|
1,211 |
| - share capital |
18
|
18
|
17 |
| Employees (average) |
25
|
29
|
34 |
Financial ratios
| Fiscal year | 2025/06 (consolidated) | 2024/06 (consolidated) | 2023/06 (consolidated) |
| Solvency |
67.8%
|
61.1%
|
62.5% |
| Turnover per employee |
89
|
65
|
91 |
| Profit as a percentage of turnover |
-7.3%
|
-15.7%
|
0.9% |
| Return on assets (ROA) |
-7.8%
|
-13.2%
|
2.4% |
| Current ratio |
280.2%
|
281.1%
|
389.6% |
| Return on equity (ROE) |
-12.7%
|
-23.4%
|
2.4% |
| Change turnover |
317
|
-1,328
|
684 |
| Change turnover % |
17%
|
-41% | |
| Chg. No. of employees |
-4
|
-5
|
32 |
| Chg. No. of employees % |
-14%
|
-15% |
Total value of public sale
| Fiscal year | 2025/06 (consolidated) | 2024/06 (consolidated) | 2023/06 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.